Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Liraglutide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07025356CompletedPrimary

Observational Study of the the Use of a Trigeminal Vagal Nerve Stimulator in the Routine Care of Native Americans With Diabetic Neuropathy Pain. Pain Scores, Drug Use and Glucose Measurements Will be Assessed

NCT04232995Not ApplicableCompletedPrimary

Balance Training in Diabetic Neuropathy

NCT03426085Phase 2Unknown

The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

Showing all 3 trials

Research Network

Common Treatments

  • Liraglutide1
  • Implantation Of A Trigeminal Vagus Cervical Nerve Stimulator System1
  • Implantation Of A Neurostimulator System For Trigeminal Vagal Cervical Nerve Stimulation1
  • Balance Training1
  • General Exercises1

Active Sponsors

  • Dow University of Health Sciences1
  • Vagus Nerve Society1
  • Eastern Virginia Medical School1

Top Investigators

Related Conditions

  • Sweat Gland Diseases1
  • Autonomic Nervous System Diseases1

Activity Timeline